Given the results from the BILCAP trial presented at ASCO, would you change to or initiate therapy with capecitabine for patients with biliary tract cancer in the post-operative setting?
For patients receiving adjuvant gemcitabine alone, would you now switch to adjuvant capecitabine alone?